Share Name Share Symbol Market Type Share ISIN Share Description
Integumen LSE:SKIN London Ordinary Share GB00BYWJ6269 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 2.625p 2.50p 2.75p 2.625p 2.625p 2.625p 60,000 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
0.1 -1.1 29.0 0.1 4.35

Integumen Share Discussion Threads

Showing 26 to 47 of 50 messages
Chat Pages: 2  1
DateSubjectAuthorDiscuss
15/8/2017
18:22
Probably some initial investor selling out
cocker
15/8/2017
17:16
So what's going on today, news coming, looks like an exodus!
admac
03/7/2017
10:39
This is a dead ducky !!! No movements at all.
philoosh
02/6/2017
16:58
I clearly need to go back to the 80's, get a sharp suit and go back to BS sales school.
yump
02/6/2017
16:44
I don't know Yump, promise the earth & tell peeps global market worth 2 billion a year. Then place begging bowl out every six months & see how things turn out. What would be interesting is to know how many aim listed companies actually make a profit or get anywhere near their predicted revenues. Aim has always been a bit if a gamble & I except that. However, of late it has become a circus.
cocker
02/6/2017
16:22
Wow, they've just made more revenue than one of my websites, except that the expenses for it are in thousands... I wonder if I could float for a couple of mill ? The only problem is I don't have any story other than 'to make profits from running a website', so a float is a non-starter ;-)
yump
02/6/2017
13:57
There has been no movement on this since its IPO other than down. Is there any future in this share ?
philoosh
02/6/2017
08:11
Exciting set of results !. Give it 12 more months before the begging bowl is out again
cocker
08/5/2017
12:13
Well this seems to be a very lazy puppy !!!
philoosh
11/4/2017
07:13
New Asian supply contract for Integumen's TS1 and first orders received - over 500,000 of these disposable products have already been sold by Integumen: Http://www.investegate.co.uk/integumen-plc--skin-/rns/supply-agreement-in-asia/201704110700171060C/
rivaldo
08/4/2017
14:34
Thanks Griffin81
orm5
08/4/2017
11:23
I don't think the website shows up on google searches yet. Links below to SKIN and the company it has been spun out from:http://www.integumen.co.uk/http://www.vennlifesciences.com/ipo-integumen-plc/
griffin81
07/4/2017
20:41
Does this company have a website ?
orm5
07/4/2017
20:22
I guess some shares are not for the faint hearted if you are trading day to day.
mulligut
07/4/2017
11:37
heading for half a penny
larva
06/4/2017
14:34
Rivaldo I am not a day trader so none of that particularly causes me any major concern. This is another share just like any other and hopefully based on what was done with Venn their management can drive value in the long term. I would expect that a decent newsflow regime for breakthrough products and distribution agreements will do a good bit for the share price. Long term it remains a very small part of my portfolio.
mulligut
06/4/2017
11:44
Rivaldo. Just goes to show how many threads I have set up. Okay I agree that would be a good idea and the new thread is http://uk.advfn.com/cmn/fbb/thread.php3?id=41052994 here.
mulligut
06/4/2017
11:42
Integumen has acquired and developed an advanced portfolio of technologies focused on premium products for the skin, oral and health care sector. Management have extensive experience in the commercialisation of these technologies with access to direct retail market distribution channels. Recent funding and admission to AIM has provided the support and public media exposure to further commercialise its already launched products, and bring its late stage development portfolio to market. With more than half a million Tongue Sanitisation disposable oral hygiene products sold since 2015, there is an opportunity to expand the distribution within the dental market in a strategy of high growth offering high value for other products in the pipeline. “Enhance Skin”, “Visible Youth” and “Clarogel̶1; product range of consumer and professional skincare products offer a consumer brand backed up by patented co-formulation of medical grade hyaluronic acid (HA). This offers additional opportunities for extension of distribution channels in Europe and the US. “Labskin”; provides unique access to in-house assessment of skin care ingredients and formulations offering accelerated evaluation to the most comprehensive range of tests available in an in vitro model, leading to early commercialisation of existing and future product formulations. The above is my assessment of the opportunity and I have decided to spread some of my monthly buying of Venn to a small purchase of shares in this company for the next few months. In the interest of fredome of speech, I welcome any comments, positive, in support or otherwise. Good luck to all.
mulligut
06/4/2017
11:17
Mulligut, thx for setting this up. Being a pedant though - you haven't actually got the name of the company in the thread! Which doesn't help with publicising it. Perhaps you could set up a replacement thread called "Integumen - skin in the game"? No probs if you can't be bothered!
rivaldo
06/4/2017
09:39
!FOLLOWFEED Integumen has acquired and developed an advanced portfolio of technologies focused on premium products for the skin, oral and health care sector. Management have extensive experience in the commercialisation of these technologies with access to direct retail market distribution channels. Recent funding and admission to AIM has provided the support and public media exposure to further commercialise its already launched products, and bring its late stage development portfolio to market. With more than half a million Tongue Sanitisation disposable oral hygiene products sold since 2015, there is an opportunity to expand the distribution within the dental market in a strategy of high growth offering high value for other products in the pipeline. “Enhance Skin”, “Visible Youth” and “Clarogel̶1; product range of consumer and professional skincare products offer a consumer brand backed up by patented co-formulation of medical grade hyaluronic acid (HA). This offers additional opportunities for extension of distribution channels in Europe and the US. “Labskin”; provides unique access to in-house assessment of skin care ingredients and formulations offering accelerated evaluation to the most comprehensive range of tests available in an in vitro model, leading to early commercialisation of existing and future product formulations. The above is my assessment of the opportunity and I have decided to spread some of my monthly buying of Venn to a small purchase of shares in this company for the next few months. In the interest of fredome of speech, I welcome any comments, positive, in support or otherwise. Good luck to all.
mulligut
04/4/2016
14:44
Indeed you are homo, indeed you are.
o1dsmokie
01/4/2016
09:22
Nah, I regret all my cutting remarks about you! HA HA APRIL FOOL!!!!
e j blythe
Chat Pages: 2  1
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170821 21:45:33